BACKGROUND: The effectiveness of the CMS nonpayment policy for certain hospital-acquired conditions (HAC) is debated, since their preventability is questionable in several groups of patients. This study aimed to determine the rate of the three most common HAC in major surgical resections for cancer: surgical site infection (SSI), urinary tract infection (UTI), and venous thromboembolism (VTE). Additionally, the association of HAC with patients' characteristics and their effect on post-operative outcomes were investigated. METHODS: Patients who underwent surgical resection for esophageal, gastric, hepato-biliary, pancreatic, colorectal, and lung cancer were identified using the ACS-NSQIP database (2005-2012). Early surgical outcomes were compared between HAC and non-HAC patients. Modified Poisson regression was used to identify risk factors for developing HAC. RESULTS: Seventy-four thousand three hundred eighty-one patients were identified, of whom 9,479 (12.74%) developed one or more HAC. HAC patients had significantly higher rates of 30-day mortality, return to operating room, 30-day readmission, had longer LOS, and were less likely to be discharged home. Several peri-operative patients' factors were significantly associated with HAC. CONCLUSION: Our data show that the development of HAC is strongly associated to pre-operative patients' characteristics and not only to sub-optimal peri-operative care, therefore suggesting that the nonpayment policy might be excessively penalizing.
BACKGROUND: The effectiveness of the CMS nonpayment policy for certain hospital-acquired conditions (HAC) is debated, since their preventability is questionable in several groups of patients. This study aimed to determine the rate of the three most common HAC in major surgical resections for cancer: surgical site infection (SSI), urinary tract infection (UTI), and venous thromboembolism (VTE). Additionally, the association of HAC with patients' characteristics and their effect on post-operative outcomes were investigated. METHODS:Patients who underwent surgical resection for esophageal, gastric, hepato-biliary, pancreatic, colorectal, and lung cancer were identified using the ACS-NSQIP database (2005-2012). Early surgical outcomes were compared between HAC and non-HAC patients. Modified Poisson regression was used to identify risk factors for developing HAC. RESULTS: Seventy-four thousand three hundred eighty-one patients were identified, of whom 9,479 (12.74%) developed one or more HAC. HAC patients had significantly higher rates of 30-day mortality, return to operating room, 30-day readmission, had longer LOS, and were less likely to be discharged home. Several peri-operative patients' factors were significantly associated with HAC. CONCLUSION: Our data show that the development of HAC is strongly associated to pre-operative patients' characteristics and not only to sub-optimal peri-operative care, therefore suggesting that the nonpayment policy might be excessively penalizing.
Authors: E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245
Authors: P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast Journal: N Engl J Med Date: 2012-05-31 Impact factor: 91.245
Authors: Bruce L Hall; Barton H Hamilton; Karen Richards; Karl Y Bilimoria; Mark E Cohen; Clifford Y Ko Journal: Ann Surg Date: 2009-09 Impact factor: 12.969
Authors: Grace M Lee; Ken Kleinman; Stephen B Soumerai; Alison Tse; David Cole; Scott K Fridkin; Teresa Horan; Richard Platt; Charlene Gay; William Kassler; Donald A Goldmann; John Jernigan; Ashish K Jha Journal: N Engl J Med Date: 2012-10-11 Impact factor: 91.245
Authors: Hishaam Ismael; Mathilda Horst; Maria Farooq; Jack Jordon; Joe H Patton; Ilan S Rubinfeld Journal: Am J Surg Date: 2011-03 Impact factor: 2.565
Authors: Jyoti D Patel; Lada Krilov; Sylvia Adams; Carol Aghajanian; Ethan Basch; Marcia S Brose; William L Carroll; Marcos de Lima; Mark R Gilbert; Mark G Kris; John L Marshall; Gregory A Masters; Steven J O'Day; Blasé Polite; Gary K Schwartz; Sunil Sharma; Ian Thompson; Nicholas J Vogelzang; Bruce J Roth Journal: J Clin Oncol Date: 2013-12-10 Impact factor: 44.544
Authors: Linda R Duska; Leslie Garrett; Melissa Henretta; J Stuart Ferriss; Lisa Lee; Neil Horowitz Journal: Gynecol Oncol Date: 2010-03 Impact factor: 5.482
Authors: Benjamin Müssle; Nathalie Buck; Stephanie Schade; Marian Sommer; Florian Oehme; Andreas Bogner; Sebastian Hempel; Christoph Radosa; Christoph Kahlert; Marius Distler; Jürgen Weitz; Thilo Welsch Journal: Langenbecks Arch Surg Date: 2020-10-09 Impact factor: 3.445
Authors: Scott K Sherman; Jennifer E Hrabe; Emily Huang; John W Cromwell; John C Byrn Journal: J Gastrointest Surg Date: 2018-04-23 Impact factor: 3.452
Authors: Sumer K Wallace; Jessica W Halverson; Christopher J Jankowski; Stephanie R DeJong; Amy L Weaver; Megan R Weinhold; Bijan J Borah; James P Moriarty; William A Cliby; Daryl J Kor; Andrew A Higgins; Hilary A Otto; Sean C Dowdy; Jamie N Bakkum-Gamez Journal: Obstet Gynecol Date: 2018-05 Impact factor: 7.661
Authors: Frank W Brennfleck; Lena Linsenmeier; Henrik H G Junger; Katharina M Schmidt; Jens M Werner; Daniel Woehl; Florian Zeman; Ingrid Mutzbauer; James A Hutchinson; Edward K Geissler; Hans J Schlitt; Stefan M Brunner Journal: Trials Date: 2020-11-09 Impact factor: 2.279